CEO & Co-Founder

PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence

All the companies from Y Combinator's W20 Demo Day, Part III: Hardware, Robots, AI and Developer Tools

PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding

PostEra announces $260M multi-target strategic AI Lab collaboration with Pfizer

General Interest

PostEra is building a modern biopharma utilizing their AI platform, Proton, to accelerate medicinal chemistry and new medicine discovery. They focus on Women's Health and Reproductive Medicine while fostering partnerships with biopharma, and they are actively involved in open-science initiatives for pandemic preparedness.

Sign up with Google

Sign in with Google